FMC Corporation and Corteva Agriscience collaborate to provide fluindapyr fungicide technology to more U.S. growers
- Strategic partnership expands market reach to 175 million planted acres across U.S. corn and soybean markets
- Fluindapyr technology provides extended residual control and manages pathogen resistance effectively
- Product already successfully commercialized in multiple countries with more launches planned
- Partnership with Corteva enhances distribution and market penetration capabilities
- Corteva's product launch is dependent on pending EPA registration
- Market expansion won't begin until 2026 growing season
Insights
FMC-Corteva partnership expands fluindapyr fungicide distribution in massive corn and soybean markets, boosting FMC's market reach.
This strategic agreement between FMC and Corteva represents a significant market expansion opportunity for FMC's innovative fluindapyr fungicide technology. The partnership targets the enormous U.S. corn and soybean markets, which cover approximately
The technical significance of fluindapyr shouldn't be understated. As a Group 7 fungicide, it provides extended residual control against challenging diseases like tar spot and southern rust. More importantly, it effectively manages pathogens that have developed resistance to other fungicide classes – a growing concern in modern agriculture where effective rotation of chemical modes of action is essential for sustainable disease management.
This collaboration model allows FMC to maintain its existing product line while simultaneously expanding technology reach through a competitor's distribution channels. The agreement extends FMC's commercial presence beyond the seven countries where fluindapyr products are already available, with Corteva planning to launch its fluindapyr-based product for the 2026 growing season, pending EPA registration.
For U.S. corn and soybean growers, this partnership means broader access to advanced disease management tools, particularly against increasingly problematic foliar diseases that can significantly impact yield potential. The agreement demonstrates how competitive agricultural input companies can collaborate on technology deployment while maintaining distinct product offerings, ultimately providing farmers with more robust disease management options.
Under the terms of the agreement, both companies will market fluindapyr-based fungicide products to
"This strategic agreement will introduce FMC's innovative fluindapyr technology into a broader segment of the
Fluindapyr, the active ingredient in Adastrio® fungicide, provides extended residual control and effectively manages pathogens that have developed resistance to other fungicide classes, making it an essential component in a comprehensive resistance management strategy. Fluindapyr is classified by the Fungicide Resistance Action Committee (FRAC) as a Group 7 fungicide.
"One of our goals is to make sure farmers have what they need to grow and harvest a successful crop," said Jeremy Dirks, president, Corteva North America. "With the novel active ingredient, fluindapyr, we can provide growers with an additional effective disease management tool that complements the other fungicides in our portfolio."
FMC has commercialized products containing fluindapyr in
For more information about Adastrio® fungicide, visit ag.fmc.com/adastrio-fungicide.
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.
Adastrio is a trademark of FMC Corporation and/or an affiliate. Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.
In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2024 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-and-corteva-agriscience-collaborate-to-provide-fluindapyr-fungicide-technology-to-more-us-growers-302472425.html
SOURCE FMC Corporation